Research at the University of Wisconsin-Eau Claire is now backed by the Mayo Clinic Health System thanks to their ...

Groundbreaking research by Sydney University found a new brain protein involved in Parkinson’s disease and a way to modify it ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

His work blended classic design with a loose ’60s-style energy, giving publications like Rolling Stone an identity that ...

A groundbreaking brain imaging study shows why the gold-standard Parkinson’s drug doesn’t work for everyone—and how doctors ...

Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...

These findings highlight the significance of rearing behavior and behavioral lateralization as potential behavioral markers ...

A breakthrough brain scan shows Parkinson’s drugs can misfire in the brain, helping some patients less than others. The fix?

In a breakthrough study, scientists found that silencing a single overactive enzyme in the brain reversed early damage caused ...

Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been in the headlines lately, owing in large ...

Inhibiting an overabundant enzyme saved a key component of a brain signaling pathway that is vital for motor control in a ...